Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy. | Front Immunol | 2023 | 37744383 | PubTator, text mining | PubMed |
| PDK4 facilitates fibroblast functions and diabetic wound healing through regulation of HIF-1α protein stability and gene expression. | FASEB J | 2023 | 37737961 | PubTator, text mining | PubMed |
| The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways. | Cell Commun Signal | 2023 | 37735675 | PubTator, text mining | PubMed |
| Angiotensin-Converting Enzyme (ACE) gene polymorphism and arterial blood pressure among the Tawang Monpa of Eastern Himalayan Mountains: Is there a signature of natural selection? | PLoS One | 2023 | 37733712 | PubTator, text mining | PubMed |
| Genetic Origins and Adaptive Evolution of the Deng People on the Tibetan Plateau. | Mol Biol Evol | 2023 | 37713634 | PubTator, text mining | PubMed |
| Börjeson-Forssman-Lehmann syndrome: delineating the clinical and allelic spectrum in 14 new families. | Eur J Hum Genet | 2023 | 37704779 | PubTator, text mining | PubMed |
| LINC02774 inhibits glycolysis in glioma to destabilize HIF-1α dependent on transcription factor RP58. | MedComm (2020) | 2023 | 37701531 | PubTator, text mining | PubMed |
| Potential targets of natural medicines: preventing lung cancer pre-metastatic niche formation by regulating exosomes. | Front Oncol | 2023 | 37700835 | PubTator, text mining | PubMed |
| Transcriptomic Response of Differentiating Porcine Myotubes to Thermal Stress and Donor Piglet Age. | Int J Mol Sci | 2023 | 37686405 | PubTator, text mining | PubMed |
| Significance of Intra-plaque Hemorrhage for the Development of High-Risk Vulnerable Plaque: Current Understanding from Basic to Clinical Points of View. | Int J Mol Sci | 2023 | 37686106 | PubTator, text mining | PubMed |
| The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy. | Commun Biol | 2023 | 37684337 | PubTator, text mining | PubMed |
| Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches. | Front Oncol | 2023 | 37681032 | PubTator, text mining | PubMed |
| Global dispersal and adaptive evolution of domestic cattle: a genomic perspective. | Stress Biol | 2023 | 37676580 | PubTator, text mining | PubMed |
| Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progress. | Neuroprotection | 2023 | 37671067 | PubTator, text mining | PubMed |
| Exploring the natural products chemical space through a molecular search to discover potential inhibitors that target the hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD). | Front Pharmacol | 2023 | 37670941 | PubTator, text mining | PubMed |
| The role of non-coding RNAs in extracellular vesicles in breast cancer and their diagnostic implications. | Oncogene | 2023 | 37670020 | PubTator, text mining | PubMed |
| Expression of hypoxia-inducible genes is suppressed in altered gravity due to impaired nuclear HIF1α accumulation. | Sci Rep | 2023 | 37666879 | PubTator, text mining | PubMed |
| Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19. | iScience | 2023 | 37664617 | PubTator, text mining | PubMed |
| A mitochondrial EglN1-AMPKα axis drives breast cancer progression by enhancing metabolic adaptation to hypoxic stress. | EMBO J | 2023 | 37661833 | PubTator, text mining | PubMed |
| Mitochondria in hypoxic pulmonary hypertension, roles and the potential targets. | Front Physiol | 2023 | 37645564 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers?page=17